Palvella Therapeutics, Inc. PVLA

138.16 (7.91) (5.42%) as of 25 Sep

Follow PVLA

Revenue Champion (3y) Insider Buys (last 12m)

Growth Flags show if company had growth for consecutive years,

Insider Buys alert about insiders buying in the last 12 month

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	(46.63%)	(34.25%)	(92.10%)	(117.82%)	+8 more TTM periods Free account
ROA Full definition →	(37.70%)	(28.73%)	(56.45%)	(74.02%)
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	(25.59%)	(19.40%)	(87.56%)	(57.17%)
Average Days of Receivables Full definition →	—	—	—	0.00
Free Cash Flow per Share Full definition →	(2.54)	(2.22)	(2.22)	(2.30)
Free Cash Flow Full definition →	(36.51)	(29.10)	(25.01)	(25.47)
Other line items
Cash ROIC Full definition →	(7.81%)	(5.89%)	(29.09%)	(24.91%)
Accounts Receivable Turnover Full definition →	—	—	—	0.00
Accounts Payable Turnover Full definition →	0.00	0.00	0.00	0.00
Average Days of Payables Full definition →	0.00	0.00	0.00	0.00
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Interest Coverage Full definition →	0.00	0.00	0.00	0.00
Operating CF/Net income Full definition →	0.59	0.59	0.60	0.79
Revenue per Share Full definition →	0.00	0.00	0.00	0.00
Operating CF per Share Full definition →	(2.54)	(2.22)	(2.22)	(2.30)
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Net Profit Margin Full definition →	0.00%	0.00%	0.00%	0.00%

Columns are period end dates

Powerpack